
Organic and Biomolecular Chemistry p. 1532 - 1544 (2003)
Update date:2022-08-04
Topics:
Ashweek, Neil J.
Coldham, Iain
Haxell, Thomas F.N.
Howard, Steven
The synthesis of chiral 1,2-diamines and 1,3-diamines was achieved from the unsubstituted diamines by way of N-tert-butoxycarbonyl (Boc) substituted imidazolidines (tetrahydroimidazoles) and pyrimidines (hexahydro-1,3-diazines), which were treated with sec-butyllithium to effect deprotonation a- to the N-Boc group, followed by addition of an electrophile to give substituted products that could be hydrolysed under acidic conditions to give the substituted 1,2- or 1,3-diamines. Use of the chiral ligand (-)-sparteine promoted asymmetric deprotonation of the imidazolidine substrates to give, after hydrolysis, enantiomerically enriched 1,2-diamines.
View MoreSuzhou Jingye Medicine & Chemical Co., Ltd
Contact:+86-512-66658588
Address:No. 88, Sanlian Street, Jinfeng Road, Suzhou New District, Jiangsu Province, P. R. China
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
Shanghai Dianyang Industry Co.,ltd
Contact:+86 21 6492 4669
Address:Chejing RD, Songjiang District, Shanghai, China
Contact:+49-9398-993127
Address:Untertorstr. 27
Doi:10.1016/0040-4020(76)85044-2
(1976)Doi:10.1021/jm970522y
(1997)Doi:10.1055/s-0034-1379942
(2015)Doi:10.1021/om9800804
(1998)Doi:10.1021/om971062+
(1998)Doi:10.1039/a800603b
(1998)